These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Neglected and underrepresented subpopulations: elderly and performance status 2 patients with advanced-stage non-small-cell lung cancer. Langer CJ Clin Lung Cancer; 2006 May; 7 Suppl 4():S126-37. PubMed ID: 16764753 [TBL] [Abstract][Full Text] [Related]
5. Medical treatment of advanced non-small cell lung cancer in elderly patients: a review of the role of chemotherapy and targeted agents. Meoni G; Cecere FL; Lucherini E; Di Costanzo F J Geriatr Oncol; 2013 Jul; 4(3):282-90. PubMed ID: 24070465 [TBL] [Abstract][Full Text] [Related]
6. Treatment of advanced non-small-cell lung cancer in the elderly: results of an international expert panel. Gridelli C; Aapro M; Ardizzoni A; Balducci L; De Marinis F; Kelly K; Le Chevalier T; Manegold C; Perrone F; Rosell R; Shepherd F; De Petris L; Di Maio M; Langer C J Clin Oncol; 2005 May; 23(13):3125-37. PubMed ID: 15860872 [TBL] [Abstract][Full Text] [Related]
7. [Treatment of the unresectable non small cell lung carcinoma]. Spásová I Cas Lek Cesk; 2005; 144(9):602-12; discussion 612-3. PubMed ID: 16193938 [TBL] [Abstract][Full Text] [Related]
8. Elderly patients benefit from second-line cytotoxic chemotherapy: a subset analysis of a randomized phase III trial of pemetrexed compared with docetaxel in patients with previously treated advanced non-small-cell lung cancer. Weiss GJ; Langer C; Rosell R; Hanna N; Shepherd F; Einhorn LH; Nguyen B; Paul S; McAndrews P; Bunn PA; Kelly K J Clin Oncol; 2006 Sep; 24(27):4405-11. PubMed ID: 16983108 [TBL] [Abstract][Full Text] [Related]
11. Treatment of advanced non-small-cell lung cancer: Italian Association of Thoracic Oncology (AIOT) clinical practice guidelines. de Marinis F; Rossi A; Di Maio M; Ricciardi S; Gridelli C; Lung Cancer; 2011 Jul; 73(1):1-10. PubMed ID: 21440325 [TBL] [Abstract][Full Text] [Related]
12. [Gemcitabine in the first line therapy of advanced and metastatic non-small-cell lung carcinoma (NSCLC): review of the results of phase III studies]. Langer F; Helsberg K; Schütte WH; Leschinger MI Onkologie; 2005 Mar; 28 Suppl 1():1-28. PubMed ID: 15802886 [TBL] [Abstract][Full Text] [Related]
13. Treatment of advanced non-small-cell lung cancer in the elderly. Gridelli C; Maione P; Rossi A; Ferrara ML; Castaldo V; Palazzolo G; Mazzeo N Lung Cancer; 2009 Dec; 66(3):282-6. PubMed ID: 19879012 [TBL] [Abstract][Full Text] [Related]
14. A systematic overview of chemotherapy effects in non-small cell lung cancer. Sörenson S; Glimelius B; Nygren P; Acta Oncol; 2001; 40(2-3):327-39. PubMed ID: 11441939 [TBL] [Abstract][Full Text] [Related]
15. Comparison of Carboplatin Plus Pemetrexed Followed by Maintenance Pemetrexed With Docetaxel Monotherapy in Elderly Patients With Advanced Nonsquamous Non-Small Cell Lung Cancer: A Phase 3 Randomized Clinical Trial. Okamoto I; Nokihara H; Nomura S; Niho S; Sugawara S; Horinouchi H; Azuma K; Yoneshima Y; Murakami H; Hosomi Y; Atagi S; Ozaki T; Horiike A; Fujita Y; Okamoto H; Ando M; Yamamoto N; Ohe Y; Nakagawa K JAMA Oncol; 2020 May; 6(5):e196828. PubMed ID: 32163097 [TBL] [Abstract][Full Text] [Related]
16. Management of non-small cell lung in cancer patients with stable disease. Grossi F Drugs; 2012 Jun; 72 Suppl 1():20-7. PubMed ID: 22712794 [TBL] [Abstract][Full Text] [Related]
18. Elderly subgroup analysis of a randomized phase III study of docetaxel plus platinum combinations versus vinorelbine plus cisplatin for first-line treatment of advanced nonsmall cell lung carcinoma (TAX 326). Belani CP; Fossella F Cancer; 2005 Dec; 104(12):2766-74. PubMed ID: 16288485 [TBL] [Abstract][Full Text] [Related]
19. Meta-analysis examining impact of age on overall survival with pemetrexed for the treatment of advanced non-squamous non-small cell lung cancer. Paz-Ares LG; Zimmermann A; Ciuleanu T; Bunn PA; Antonio BS; Denne J; Iturria N; John W; Scagliotti GV Lung Cancer; 2017 Feb; 104():45-51. PubMed ID: 28212999 [TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of erlotinib versus chemotherapy in second-line treatment of patients with advanced, non-small-cell lung cancer with poor prognosis (TITAN): a randomised multicentre, open-label, phase 3 study. Ciuleanu T; Stelmakh L; Cicenas S; Miliauskas S; Grigorescu AC; Hillenbach C; Johannsdottir HK; Klughammer B; Gonzalez EE Lancet Oncol; 2012 Mar; 13(3):300-8. PubMed ID: 22277837 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]